BLACK FRIDAY SALE:  20% OFF   SITEWIDE PRODUCTS – USE CODE [BF2024]  AT CHECKOUT

Leaders in Research Peptides

(£) GBP (Default)
  • ($) USD
  • (€) EUR
  • ($) AUD
  • ($) CAD
  • ($) NZD
(£) GBP (Default)
  • ($) USD
  • (€) EUR
  • ($) AUD
  • ($) CAD
  • ($) NZD

CJC-1295 No-Dac 2mg Pre Mixed

£24.74£66.79

CJC-1295 No DAC 2mg Pre Mixed, a well-known Growth Hormone Releasing Peptide (GHRP), is an amino acid-based peptide hormone, which has been demonstrated in Finland studies to improve lean muscle mass, increase muscle strength, and reduce body fat.

Pre Mixed Cartridge and Kit:

  • 1 x Cartridge (The cartridge is premixed with the peptide vial of your choice and Bacteriostatic Water)
  • 1 x Peptide Cartridge Pen
  • 1 x Pen Carry Case
  • 3 x Pen Needle Tips

Single Mixed Cartridges (1,2 & 3) Come with:


  • 1,2 or 3 x Cartridge (The cartridge is premixed with the peptide vial of your choice and Bacteriostatic Water)
  • 3 x Pen Needle Tips

The single 1,2 & 3 cartridges do not come with a kit. Save 10% when buying 3 cartridges.

Buy 10 and get 10% Discount

594 in stock

Description

Buy CJC-1295 No DAC 2mg Pre Mixed

This product is intended for research purposes only. To be used by trained professionals only.

The CJC-1295 No DAC 2mg Pre Mixed Pen is a user-friendly device designed for accurately administering the synthetic peptide CJC-1295 No DAC in a convenient pen format. Each pen contains 2mg of the peptide, allowing researchers to easily measure and inject it with precision. This formulation offers the same growth hormone-releasing properties as the vial and nasal spray variants, ensuring consistent dosing for experiments.

The ergonomic design simplifies the injection process, making it practical for both lab settings and clinical trials. By reducing the complexity associated with traditional vials, the pre mixed pen promotes adherence to dosing regimens and supports studies requiring frequent peptide administration. As research reveals the therapeutic and performance-enhancing potentials of CJC-1295 No DAC, the pre mixed pen is an essential tool for scientists in endocrinology, sports medicine, and metabolic health.

Discover the research applications, benefits, and diverse formulations of CJC-1295 no DAC (without Drug Affinity Complex) Peptide at Direct Peptides Finland today. Specifically designed for detailed research, this peptide explores the impact of growth hormone on anti-ageing, metabolism, protein synthesis, cognition, and sleep quality.


Key Features of CJC-1295 No DAC 2mg Pre Mixed Pen

  • User-Friendly Design: Ergonomically designed for easy handling and administration, for researchers of all experience levels.
  • Accuracy in Dosing: Each pen provides accurate dispensing of 2mg of CJC-1295 No DAC, ensuring consistent and reliable measurements for experimental needs.
  • Consistent Release Properties: Offers the same growth hormone-releasing properties as the vial and nasal spray formulations, ensuring comparable results across different delivery systems.
  • Convenient Administration: Simplifies the injection process, making it ideal for use in both laboratory settings and clinical trials where time is critical.
  • Enhanced Compliance: Facilitates adherence to dosing schedules, supporting studies with frequent peptide requirements.
  • Research Versatility: Suited for a variety of applications, including investigations into endocrine function, athletic enhancement, and metabolic health advancements.
  • Regulatory Compliance: Designed for research use only, not for human consumption, in accordance with safety regulations.

 

Discover our range of Pre-Mixed Peptide Pens at Direct Peptides Finland, designed to boost your research. We also supply high quality research grade peptide supplies for reconsitution and administration for all your research requirements.


References:

[1] S L Teichman, A Neale, B Lawrence, C Gagnon, JP Castaigne, L A Frohman (2006) Prolonged stimulation of growth hormone (GH) and insulin-like growth factor I secretion by CJC-1295, a long-acting analog of GH-releasing hormone, in healthy adults – Journal of Clinical Endocrinology and Metabolism, 2006 Mar, Volume 91 (Issue 3), Pages 799-805.

[2] M Alba, D Fintini, A Sagazio, B Lawrence, JP Castaigne, L A Frohman, and R Salvatori (2006) Once-daily administration of CJC-1295, a long-acting growth hormone-releasing hormone (GHRH) analog, normalizes growth in the GHRH knockout mouse – American Journal of Physiology, Endocrinology and Metabolism, Volume 291, Issue 6, December 2006, Pages E1290-E1294.

Research use only. Not for human or animal consumption!


ALL CONTENT AND PRODUCT INFORMATION AVAILABLE ON THIS WEBSITE IS FOR EDUCATIONAL PURPOSES ONLY.

DISCLAIMER: These products are intended solely as a research chemical only. This classification allows for their use only for research development and laboratory studies. The information available on our Finland Direct Peptides website: https://finland.direct-peptides.com is provided for educational purposes only. These products are not for human or animal use or consumption in any manner. Handling of these products should be limited to suitably qualified professionals. They are not to be classified as a drug, food, cosmetic, or medicinal product and must not be mislabelled or used as such.


BUY CJC-1295 No DAC 2mg Pre Mixed Peptide Pen ONLINE today From Finland Direct Peptides

You may also like…